Her2 low status and response to neoadjuvant chemotherapy in Her2 negative early breast cancer

被引：0

作者：

Mattos, Bruna RaphaeliSilva ^{[1
]}

Cesca, Marcelle Goldner ^{[1
]}

Leite, Luciana de Moura ^{[1
]}

Tavares, Monique Celeste ^{[1
]}

Silva, Sinara Figueiredo ^{[1
]}

Pirolli, Rafaela ^{[1
]}

Fogassa, Camilla AlbinaZanco ^{[1
]}

Silva, Erick Figueiredo ^{[1
]}

Rocha, Francisca Giselle ^{[1
]}

Loose, Simone Klug ^{[1
]}

Campos, Fernando AugustoBatista ^{[1
]}

Sanches, Solange Moraes ^{[1
]}

de Lima, Vladmir ClaudioCordeiro ^{[1
]}

Ponde, Noam Falbel ^{[1
]}

机构：

[1] AC Camargo Canc Ctr, Sao Paulo, Brazil

来源：

CANCER RESEARCH | 2021年 / 81卷 / 04期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

PS4-40

引用

页数：2

共 50 条

[1] HER2-low status and response to neoadjuvant chemotherapy in HER2 negative early breast cancer
Luciana de Moura Leite
Marcelle Goldner Cesca
Monique Celeste Tavares
Debora Maciel Santana
Erick Figueiredo Saldanha
Paula Tavares Guimarães
Daniella Dias Silva Sá
Maria Fernanda Evangelista Simões
Rafael Lima Viana
Francisca Giselle Rocha
Simone Klog Loose
Sinara Figueiredo Silva
Rafaela Pirolli
Camilla Albina Zanco Fogassa
Bruna Raphaeli Silva Mattos
Fernando Augusto Batista Campos
Solange Moraes Sanches
Vladmir Cláudio Cordeiro de Lima
Noam Falbel Pondé
[J]. Breast Cancer Research and Treatment, 2021, 190 : 155 - 163
[2] HER2-low status and response to neoadjuvant chemotherapy in HER2 negative early breast cancer
de Moura Leite, Luciana
Cesca, Marcelle Goldner
Tavares, Monique Celeste
Santana, Debora Maciel
Saldanha, Erick Figueiredo
Guimaraes, Paula Tavares
Sa, Daniella Dias Silva
Simoes, Maria Fernanda Evangelista
Viana, Rafael Lima
Rocha, Francisca Giselle
Loose, Simone Klog
Silva, Sinara Figueiredo
Pirolli, Rafaela
Fogassa, Camilla Albina Zanco
Mattos, Bruna Raphaeli Silva
Campos, Fernando Augusto Batista
Sanches, Solange Moraes
de Lima, Vladmir Claudio Cordeiro
Ponde, Noam Falbel
[J]. BREAST CANCER RESEARCH AND TREATMENT, 2021, 190 (01) : 155 - 163
[3] Methodology Used to Determine HER2 Status Correlates with Response to Neoadjuvant Chemotherapy in HER2 Positive Breast Cancer
Cheng, Esther
McIntire, Patrick
D'Alfonso, Timothy
Ginter, Paula
[J]. MODERN PATHOLOGY, 2018, 31 : 54 - 54
[4] Methodology Used to Determine HER2 Status Correlates with Response to Neoadjuvant Chemotherapy in HER2 Positive Breast Cancer
Cheng, Esther
McIntire, Patrick
D'Alfonso, Timothy
Ginter, Paula
[J]. LABORATORY INVESTIGATION, 2018, 98 : 54 - 54
[5] Neoadjuvant chemotherapy with HER2 inhibitors for breast cancer response
Brede-Hekimian, Katya
[J]. LANCET, 2012, 379 (9833): : 2237 - 2237
[6] Impact of HER2 Status on Pathological Response after Neoadjuvant Chemotherapy in Early Triple-Negative Breast Cancer
Domergue, Camille
Martin, Elodie
Lemarie, Camille
Jezequel, Pascal
Frenel, Jean-Sebastien
Augereau, Paule
Campone, Mario
Patsouris, Anne
[J]. CANCERS, 2022, 14 (10)
[7] Significance of HER2 Status in Neoadjuvant Chemotherapy for Breast Cancer Patients
Wang, Chengqin
Xing, Xiaoming
Chen, Zhaoxu
Wei, Zhimin
Li, Yujun
[J]. LABORATORY INVESTIGATION, 2023, 103 (03) : S226 - S228
[8] Response to neoadjuvant chemotherapy among women with triple-negative breast cancer by HER2 expression status
Budhathoki, Pravash
Shah, Anish
Gaire, Suman
Joshi, Utsav
Yadav, Siddhartha
[J]. CANCER RESEARCH, 2023, 83 (05)
[9] Influence of Neoadjuvant Chemotherapy on HER2/neu Status in Invasive Breast Cancer
Li, Peifeng
Liu, Tantan
Wang, Yingmei
Shao, Shuai
Zhang, Weichen
Lv, Yang
Yi, Jun
Wang, Zhe
[J]. CLINICAL BREAST CANCER, 2013, 13 (01) : 53 - 60
[10] Prognostic significance and evolution of HER2 zero, HER2 low and HER2 positive in breast cancer after neoadjuvant treatment
Wei, T.
Wang, D.
Peng, Y.
[J]. ANNALS OF ONCOLOGY, 2023, 34 : S301 - S302

← 1 2 3 4 5 →